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INTRODUC TION: THE 1999 
CL A SSIFIC ATION OF PERIODONTITIS
Periodontitis	 is	 characterized	 by	 microbially‐associated,	 host‐me‐











microbial	 challenge	within	 the	gingival	 sulcus	area	once	 inflamma‐
tion	has	initiated.	Current	evidence	supports	multifactorial	disease	
















International	Workshop	 on	Classification	 of	 Periodontal	Diseases,	
research	in	the	field	emphasized	individual	features	of	periodontitis	
and	thus	differences	 in	phenotype.	These	emerged	from	the	 iden‐
tification	 of	 specific	 bacteria	 or	 bacterial	 complexes	 as	 etiologic	
agents	of	periodontitis,3	the	recognition	of	the	existence	of	multiple	
modifiable	 risk	 factors,4	 and	 the	 identification	of	 the	 relevance	of	
genetic	susceptibility5,6	and	specific	polymorphisms	associated	with	
disease	severity.7	The	research	perspective	on	the	disease	impacted	














The	 1999	 group	 consensus	 report	 on	 aggressive	 periodontitis	
identified	 specific	 features	 of	 this	 form	 of	 disease	 and	 proposed	
the	existence	of	major	and	minor	criteria	for	case	definition	as	well	




more	 easily	 and,	 with	 appropriate	 therapy	 and	maintenance	 care,	
would	 rarely	 jeopardize	 the	 retention	 of	 a	 functional	 dentition.9 
The	 rationale	 for	 differentiating	 between	 chronic	 and	 aggressive	
periodontitis	included	the	ability	to	identify	and	focus	on	the	more	
problematic	 cases:	 presenting	 with	 greater	 severity	 earlier	 in	 life,	
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differentiate	 between	 aggressive	 and	 chronic	 periodontitis	 cases,	
and	these	difficulties	have	been	a	major	rationale	for	a	new	classifi‐
cation	workshop.11
SUMMARY AND INTERPRETATION OF 
E VIDENCE FROM CURRENT WORKSHOP 
POSITION PAPERS
To	 update	 evidence	 that	 has	 accumulated	 since	 the	 latest	 clas‐
sification	 workshop,	 the	 organizing	 committee	 commissioned	 a	
review	on	acute	periodontal	lesions	including	necrotizing	periodon‐
titis,12	 a	 review	of	manifestations	of	 systemic	diseases	 that	 affect	
the	 periodontal	 attachment	 apparatus,13	 and	 three	 position	 pa‐





1. There	 is	 no	 evidence	 of	 specific	 pathophysiology	 that	 enables	
differentiation	 of	 cases	 that	 would	 currently	 be	 classified	 as	
aggressive	 and	 chronic	 periodontitis	 or	 provides	 guidance	 for	
different	 interventions.
2. There	 is	 little	 consistent	 evidence	 that	 aggressive	 and	 chronic	
periodontitis	are	different	diseases,	but	there	is	evidence	of	mul‐
tiple	 factors,	 and	 interactions	among	 them,	 that	 influence	clini‐
cally	observable	disease	outcomes	(phenotypes)	at	the	individual	
level.	 This	 seems	 to	 be	 true	 for	 both	 aggressive	 and	 chronic	
phenotypes.
3. On	a	population	basis,	the	mean	rates	of	periodontitis	progression	












Authors’ interpretation of current evidence reviews
There is sufficient evidence to consider necrotizing periodonti-
tis as a separate disease entity.	Evidence	comes	from:	 i)	a	distinct	
pathophysiology	characterized	by	prominent	bacterial	invasion	and	




There is sufficient evidence to consider that periodontitis ob-
served in the context of systemic diseases that severely impair 
host response should be considered a periodontal manifestation 
of the systemic disease and that the primary diagnosis should 
be the systemic disease according to International Statistical 
Classification of Disease (ICD).13,17	 Many	 of	 these	 diseases	 are	
characterized	 by	 major	 functional	 impairment	 of	 host	 defenses	
and	have	multiple	non‐oral	sequelae.	At	the	moment	there	is	insuf‐
ficient	evidence	to	consider	that	periodontitis	observed	in	poorly	
controlled	 diabetes	 is	 characterized	 by	 unique	 pathophysiology	
and/or	requires	specific	periodontal	treatment	other	than	the	con‐
trol	of	both	co‐morbidities.18
Despite substantial research on aggressive periodontitis since 
the 1999 workshop,14 there is currently insufficient evidence to 
consider aggressive and chronic periodontitis as two pathophysio-
logically distinct diseases.
Current multifactorial models of disease applied to periodontitis 
appear to account for a substantial part of the phenotypic variation 
observed across cases as defined by clinical parameters.	Multiple	
observational	 studies	 in	 populations	 with	 long‐term	 exposure	 to	





It	 is	 reasonable	 to	 expect	 that	 future	 research	 advances	 will	
increase	 our	 knowledge	 of	 disease‐specific	 mechanisms	 in	 the	
context	of	the	multifactorial	biological	interactions	involved	in	spe‐
cific	 phenotypes.	 That	 pursuit	 may	 be	 valuable	 in	 guiding	 better	
management	of	 complex	 cases	 and	may	 lead	 to	novel	 approaches	
that	 enhance	 periodontitis	 prevention,	 control,	 and	 regeneration.	






dimension	 of	 the	multifactorial	 etiology	 to	 improve	 prognosis,	 ac‐
count	 for	complexity	and	 risk,	and	provide	an	appropriate	 level	of	
care	for	the	individual.
INTEGR ATING CURRENT KNOWLEDGE 
TO ADVANCE CL A SSIFIC ATION OF 
PERIODONTITIS
Clinical definition of periodontitis
Periodontitis	is	characterized	by	microbially‐associated,	host‐me‐
diated	inflammation	that	results	in	loss	of	periodontal	attachment.	
This	 is	 detected	 as	 clinical	 attachment	 loss	 (CAL)	 by	 circumfer‐
ential	 assessment	 of	 the	 erupted	 dentition	 with	 a	 standardized	
periodontal	probe	with	reference	to	the	cemento‐enamel	junction	
(CEJ).
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It	is	important	to	note:
1. Some	 clinical	 conditions	 other	 than	 periodontitis	 present	 with	
clinical	 attachment	 loss.
2. Periodontitis	 definitions	 based	 on	 marginal	 radiographic	 bone	
loss	suffer	from	severe	limitations	as	they	are	not	specific	enough	
and	 miss	 detection	 of	 mild	 to	 moderate	 periodontitis.27 
Periodontitis	definitions	based	on	radiographic	bone	loss	should	
be	 limited	 to	 the	 stages	of	mixed	dentition	and	 tooth	eruption	
when	clinical	 attachment	 level	measurement	with	 reference	 to	
the	 CEJ	 are	 impractical.28	 In	 such	 cases	 periodontitis	 assess‐
ments	based	on	marginal	radiographic	bone	loss	may	use	bitew‐
ing	radiographs	taken	for	caries	detection.
Objectives of a periodontitis case definition system
A	case	definition	 system	 should	 facilitate	 the	 identification,	 treat‐
ment	 and	 prevention	 of	 periodontitis	 in	 individual	 patients.	Given	
current	 knowledge,	 a	 periodontitis	 case	 definition	 system	 should	
include	three	components:	





Furthermore,	 case	 definitions	 may	 be	 applied	 in	 different	
contexts:	 patient	 care,	 epidemiological	 surveys	 and	 research	 on	
disease	 mechanisms	 or	 therapeutic	 outcomes,	 as	 discussed	 in	




Definition of a patient as a periodontitis case




and	 a	 periodontitis	 case	 can	 be	 identified	 with	 greater	 accuracy.	
Decreasing	the	threshold	of	CAL	increases	sensitivity.	Increasing	the	
threshold,	 requiring	CAL	at	 	≥1	 site,	 and	excluding	causes	of	CAL,	
other	than	periodontitis,	increases	specificity.
We	 should	 anticipate	 that	 until	more	 robust	methods	 are	 vali‐
dated,	 potentially	 salivary	 biomarkers	 or	 novel	 soft‐tissue	 imaging	
technologies,	the	level	of	training	and	experience	with	periodontal	
probing	will	 greatly	 influence	 the	 identification	of	 a	 case	of	 initial	
periodontitis.
It	 should	 be	 noted	 that	 periodontal	 inflammation,	 generally	
measured	 as	 bleeding	 on	 probing	 (BOP),	 is	 an	 important	 clinical	














1. Interdental	 CAL	 is	 detectable	 at	≥2	 non‐adjacent	 teeth,	 or
2. Buccal	 or	 oral	 CAL	 ≥3	mm	with	 pocketing	>3	mm	 is	 detectable	
at	≥2	teeth





























Identification of the form of periodontitis
Based	 on	 pathophysiology,	 three	 clearly	 different	 forms	 of	 peri‐
odontitis	have	been	identified:

















characteristics	 of	 a	 rare	 immune	 disorder	with	 a	 secondary	mani‐





Additional elements proposed for inclusion in the 
classification of periodontitis
Since	 the	 1999	 International	 Classification	 Workshop,	 it	 has	 be‐
come	apparent	that	additional	information	beyond	the	specific	form	
of	periodontitis	 and	 the	 severity	 and	extent	of	periodontal	 break‐







The	 degree	 of	 periodontal	 breakdown	 present	 at	 diagnosis	 has	
long	been	used	as	the	key	descriptor	of	the	individual	case	of	peri‐
odontitis.	The	1999	case	definition	system	 is	also	based	on	sever‐
ity.	 Rationale	 of	 classification	 according	 to	 severity	 encompasses	
at	least	two	important	dimensions:	complexity	of	management	and	
extent	of	disease.	 Important	 limitations	of	 severity	definitions	 are	
worth	discussing	also	in	the	context	of	recent	therapeutic	improve‐










horizontal),37	 furcation	 status,38	 tooth	mobility,39‒41	missing	 teeth,	





































Interrelationship with general health
Since	the	1999	workshop	considerable	evidence	has	emerged	con‐
cerning	 potential	 effects	 of	 periodontitis	 on	 systemic	 diseases.	
Various	mechanisms	 linking	periodontitis	 to	multiple	 systemic	dis‐
eases	 have	 been	 proposed.45,46	 Specific	 oral	 bacteria	 in	 the	 peri‐
odontal	 pocket	 may	 gain	 bloodstream	 access	 through	 ulcerated	
pocket	epithelium.	 Inflammatory	mediators	from	the	periodontium	
may	enter	the	bloodstream	and	activate	liver	acute	phase	proteins,	
such	 as	 C‐reactive	 protein	 (CRP),	 which	 further	 amplify	 systemic	
S154  |     TONETTI ET al.







Type	 II	 diabetes	 have	 shown	 value	 in	 reducing	 hyperglycemia,	 al‐
though	 reductions	 in	 hyperglycemia	 have	 not	 been	 supported	 in	
some	 larger	 studies	 where	 the	 periodontal	 treatment	 outcomes	
were	 less	 clear.18,60,61	 Although	 intriguing	 health	 economics	 anal‐
yses	 have	 shown	 a	 reduction	 in	 cost	 of	 care	 for	multiple	medical	
conditions	following	treatment	for	periodontitis,62	little	direct	peri‐
odontitis	 intervention	 evidence,	 beyond	 the	 diabetes	 experience,	
has	 convincingly	 demonstrated	 the	 potential	 value	 of	 effectively	
treating	periodontitis	relative	to	overall	health	benefits.	Current evi-
dence that effective treatment of certain cases of periodontitis can 
favorably influence systemic diseases or their surrogates, although 





of	Anesthesiologists	 (ASA)	status,	 this	can	seriously	affect	 the	cli‐
nician's	 ability	 to	 control	 disease	 progression	 due	 to	 the	 patient's	
inability	 to	withstand	proper	 treatment	or	 their	 inability	 to	attend	
necessary	maintenance	care.
FR AME WORK FOR DE VELOPING A 






The	 other	 dimension	 not	 previously	 available	 in	 our	 classifica‐
tion	is	the	directed	identification	of	individual	patients	who	are	more	
likely	 to	 require	 greater	 effort	 to	 prevent	 or	 control	 their	 chronic	
disease	 long‐term.	 This	 explicitly	 acknowledges	 the	 evidence	 that	
most	 individuals	and	patients	 respond	predictably	 to	conventional	
















of	 periodontitis	 at	 presentation	 but	 introduces	 the	 dimension	 of	
complexity	of	managing	the	individual	patient.
As	 it	 is	 recognized	 that	 individuals	 presenting	with	 different	 se‐


















granularity	 of	 the	 grade	 and	 thus	may	 increase	 the	 probability	 of	 a	
favorable	clinical	outcome.	These	concepts	have	been	adapted	to	peri‐
odontitis,	as	summarized	in	Table	1,	and	as	described	in	detail	below.





TA B L E  1  Primary	goals	in	staging	and	grading	a	patient	with	
periodontitis
Staging a Periodontitis Patient
• Goals







Grading a Periodontitis Patient
• Goals
◦ Estimate Future Risk	of	periodontitis	progression	and	
responsiveness	to	standard	therapeutic	principles,	to	guide	
intensity	of	therapy	and	monitoring
◦ Estimate Potential Health Impact of Periodontitis on 
systemic	disease	and	the	reverse,	to	guide	systemic	
monitoring	and	co‐therapy	with	medical	colleagues




















odontitis	and	 represents	 the	early	 stages	of	attachment	 loss.	As	
such,	patients	with	stage	I	periodontitis	have	developed	periodon‐
titis	 in	 response	to	persistence	of	gingival	 inflammation	and	bio‐
film	dysbiosis.	They	represent	more	 than	 just	an	early	diagnosis:	
if	 they	 show	 a	 degree	 of	 clinical	 attachment	 loss	 at	 a	 relatively	
early	 age,	 these	 patients	 may	 have	 heightened	 susceptibility	 to	




conventional	 mechanical	 biofilm	 removal	 and	 pharmacological	
agents	 delivered	 in	 oral	 hygiene	 aids.	 It	 is	 recognized	 that	 early	
diagnosis	may	 be	 a	 formidable	 challenge	 in	 general	 dental	 prac‐
tice:	periodontal	probing	to	estimate	early	clinical	attachment	loss	








of	 the	 disease	 process,	 however,	 management	 remains	 relatively	
simple	for	many	cases	as	application	of	standard	treatment	princi‐
ples	 involving	 regular	 personal	 and	 professional	 bacterial	 removal	





At	 stage	 III,	 periodontitis	 has	 produced	 significant	 damage	 to	 the	
attachment	apparatus	and,	 in	 the	absence	of	advanced	 treatment,	
tooth	loss	may	occur.	The	stage	is	characterized	by	the	presence	of	
deep	periodontal	 lesions	 that	extend	 to	 the	middle	portion	of	 the	
root	and	whose	management	is	complicated	by	the	presence	of	deep	






At	 the	more	 advanced	 stage	 IV,	 periodontitis	 causes	 considerable	
damage	to	the	periodontal	support	and	may	cause	significant	tooth	







posterior	 bite	 collapse	 and	 drifting.	 Frequently,	 case	management	
requires	stabilization/restoration	of	masticatory	function.
TA B L E  2  Framework	for	staging	and	grading	of	periodontitis
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Grade of periodontitis




medicine	 but	 has	 been	 an	 elusive	 objective	 to	 achieve	 in	 clinical	
practice.	 In	 recent	 years,	 validated	 risk	 assessment	 tools25,67 and 





odontitis	with	 high(er)	 rates	 of	 progression	 or	 presenting	with	more	





shop13–16	 have	 indicated	 that	 there	 is	 no	 evidence	 to	 suggest	 that	
such	forms	of	periodontitis	have	a	unique	pathophysiology,	rather	the	
complex	interplay	of	risk	factors	in	a	multifactorial	disease	model	may	













disease	 at	 an	 early	 age	or	minimal	 disease	 at	 advanced	 age	–	 this	
concept	has	been	used	in	clinical	practice	and	risk	assessment	tools	
to	identify	highly	susceptible	or	relatively	resistant	individuals.	One	













some	way	based	on	 number	 of	missing	 teeth	 to	 avoid	 biasing	 the	




Integrating biomarkers in a case definition system
Clinical	 parameters	 are	 very	 effective	 tools	 for	 monitoring	 the	
health‐disease	states	in	most	patients,	likely	because	they	respond	









others	 to	 develop	 and	maintain	 a	 dysbiotic	 microbiota	 in	 concert	
with	chronic	periodontal	inflammation;	it	is	unclear	whether	current	




Biomarkers	may	contribute	 to	 improved	diagnostic	accuracy	 in	
the	early	detection	of	periodontitis	and	are	likely	to	provide	decisive	
contributions	to	a	better	assessment	of	the	grade	of	periodontitis.	
They	may	 assist	 both	 in	 staging	 and	 grading	 of	 periodontitis.	 The	
proposed	framework	allows	introduction	of	validated	biomarkers	in	
the	case	definition	system.
Integrating knowledge of the interrelationship 
between periodontal health and general health in a 
case definition system
At	present	there	is	only	emerging	evidence	to	identify	specific	peri‐
odontitis	 cases	 in	 which	 periodontal	 treatment	 produces	 general	






Specific	 considerations	 for	 use	 of	 the	 staging	 and	 grading	 of	
periodontitis	with	epidemiological	and	research	applications	are	dis‐
cussed	in	Appendix	B	in	the	online	Journal of Clinical Periodontology.
INCORPOR ATION OF STAGING AND 
GR ADING IN THE C A SE DEFINITION 
SYSTEM OF PERIODONTITIS
A	 case	 definition	 system	needs	 to	 be	 a	 dynamic	 process	 that	will	
require	revisions	over	time	in	much	the	same	way	the	tumor,	node,	
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metastasis	 (TNM)	staging	system	for	cancer	has	been	shaped	over	
many	decades.	It	needs	to	be:
1. Simple	 enough	 to	 be	 clinically	 applicable	 but	 not	 simplistic:	
additional	knowledge	has	distinguished	dimensions	of	periodon‐
titis,	 such	 as	 complexity	 of	 managing	 the	 case	 to	 provide	 the	
best	 level	 of	 care










Stage of periodontitis (Table 3)
At	present,	relevant	data	are	available	to	assess	the	two	dimensions	






tor.	 It	 follows	 the	general	 frame	of	previous	severity‐based	scores	
and	is	assigned	based	on	the	worst	affected	tooth	in	the	dentition.	
Only	 attachment	 loss	 attributable	 to	 periodontitis	 is	 used	 for	 the	
score.
The	 complexity	 score	 is	 based	 on	 the	 local	 treatment	 com‐
plexity	 assuming	 the	 wish/need	 to	 eliminate	 local	 factors	 and	
takes	 into	 account	 factors	 like	 presence	 of	 vertical	 defects,	 fur‐
cation	 involvement,	 tooth	 hypermobility,	 drifting	 and/or	 flar‐
ing	of	 teeth,	 tooth	 loss,	 ridge	deficiency	and	 loss	of	masticatory	









the	 stage	 should	 not	 retrogress	 to	 a	 lower	 stage	 since	 the	 original	 stage	 complexity	 factor	 should	 always	 be	 considered	 in	 maintenance	 phase	
management.
CAL	=	clinical	attachment	loss;	RBL	=	radiographic	bone	loss.
S158  |     TONETTI ET al.














involvement,	hence	shifting	the	diagnosis	from	stage	 II	 to	stage	 III	
periodontitis.	Likewise,	if	posterior	bite	collapse	is	present	then	the	







line	 staging	will	 have	 been	 resolved	 through	 treatment.	 In	 such	
patients	 CAL	 and	 radiographic	 bone	 loss	 (RBL)	 will	 be	 the	 pri‐
mary	stage	determinants.	 If	a	stage	shifting	complexity	 factor(s)	
were	eliminated	by	treatment,	the	stage	should	not	retrogress	to	
a	 lower	 stage	 since	 the	 original	 stage	 complexity	 factor	 should	
always	be	considered	 in	maintenance	phase	management.	A	no‐
table	exception	 is	 successful	periodontal	 regeneration	 that	may,	
through	improvement	of	tooth	support,	effectively	improve	CAL	
and	RBL	of	the	specific	tooth.
Grade of periodontitis (Table 4)
Grading	adds	another	dimension	and	allows	rate	of	progression	to	





assessment	of	bone	 loss	at	 the	worst	affected	 tooth	 in	 the	den‐
tition	 as	 a	 function	 of	 age	 (measured	 as	 radiographic	 bone	 loss	






















In	 summary,	 a	 periodontitis	 diagnosis	 for	 an	 individual	 patient	
should	encompass	three	dimensions:
1. Definition	 of	 a	 periodontitis	 case	 based	 on	 detectable	 CAL	
loss	 at	 two	 non‐adjacent	 teeth
2. Identification	of	the	form	of	periodontitis:	necrotizing	periodonti‐
tis,	 periodontitis	 as	 a	 manifestation	 of	 systemic	 disease	 or	
periodontitis
3. Description	of	the	presentation	and	aggressiveness	of	the	disease	
by	stage	and	grade	 (see	Appendix	B	 in	online	Journal of Clinical 
Periodontology)
CONCLUSIONS
The	 proposed	 staging	 and	 grading	 of	 periodontitis	 provides	 an	
individual	 patient	 assessment	 that	 classifies	 patients	 by	 two	 di‐
mensions	beyond	severity	and	extent	of	disease	that	identify	pa‐
tients	as	to	complexity	of	managing	the	case	and	risk	of	the	case	






The	proposed	 staging	 and	grading	explicitly	 acknowledges	 the	
potential	 for	 some	 cases	 of	 periodontitis	 to	 influence	 systemic	
disease.	The	current	proposal	does	not	 intend	to	minimize	the	 im‐
portance	or	 extent	 of	 evidence	 supporting	direct	 distal	 effects	 of	
periodontal	 bacteremia	 on	 adverse	 pregnancy	 outcomes	 and	 po‐
tentially	other	systemic	conditions;	but	focuses	on	the	role	of	peri‐
odontitis	as	the	second	most	frequent	factor	(obesity	being	the	most	
frequent)	 that	 is	 well‐documented	 as	 a	 modifiable	 contributor	 to	
systemic	inflammatory	burden.
The	 proposed	 staging	 and	 grading	 is	 designed	 to	 avoid	 the	





periodontitis	 is	 that	 it	 is	designed	 to	accommodate	 regular	 review	
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